UCHL5 antibody
Principal name
UCHL5 antibody
Alternative names for UCHL5 antibody
UCH-L5, Ubiquitin thioesterase L5, UCH37, AD-019, CGI-70, Ubiquitin carboxyl-terminal hydrolase isozyme L5, Ubiquitin C-terminal hydrolase UCH37
Ncbi ID
9606, NP_057068, NP_001186190.1, NP_001186190, NP_001153338.1, NM_001159866, NM_019562, NM_015984
Available reactivities
Available hosts
Available applications
Frozen Sections (C), Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection))
Background of UCHL5 antibody
Covalent attachment of the C-terminus of ubiquitin to cellular proteins plays a role in a variety of cellular processes. Ubiquitin C-terminal hydrolysis is catalyzed by deubiquitinating (DUB) enzymes and is necessary for several functions, including liberation of monomeric ubiquitin from the precursors encoded by ubiquitin genes and recycling of ubiquitin monomers. There are 2 distinct families of DUBs, ubiquitin-specific proteases (UBPs) and ubiquitin C-terminal hydrolases (UCHs). Mayer and Wilkinson (1989) identified 4 distinct UCH activities from bovine thymus. All 4 were thiol proteases and had high-affinity binding sites for ubiquitin. Wilkinson et al. (1989) purified the predominant isozyme, UCHL3, and raised antibodies against it. By screening a human B-cell expression library with the antibodies, the authors isolated cDNAs encoding human UCHL3. Sequence comparisons revealed that the sequence of the predicted 230-amino acid human UCHL3 protein is 54% identical to that of UCHL1.
General readings
Yao T., et al. (2006) Nat. Cell Biol. 8:994-1002
Nishio K, et al.(2009) Biochem Biophys Res Commun. 390(3):855-60.















Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA324998 | UCHL5 antibody |
||||||
| Mouse monoclonal UCH37(UCHL5) Antibody(Ascites) | |||||||
![]() |
Mouse | IgG1 | 854CT5.5.6 | Ascites | Hu | WB |
0.1 ml /
€415.00
|
| OriGene Technologies, Inc. | |||||||
| TA325168 | UCHL5 antibody |
||||||
| Mouse monoclonal UCH37 (UCHL5) Antibody (N-term) | |||||||
![]() |
Mouse | IgG1 | 854CT5.5.6 | Purified | Hu | WB |
0.4 ml /
€415.00
|
| OriGene Technologies, Inc. | |||||||
| AP11996PU-N | UCHL5 (N-term) antibody |
||||||
![]() |
Rabbit | Ig | Purified | Hu, Ms | P, WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
+1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP302126 | UCHL5 |
||||
| Purified recombinant protein of Homo sapiens ubiquitin carboxyl-terminal hydrolase L5 (UCHL5) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216635L2V | Lenti ORF particles, Uchl5 (GFP-tagged) - Mouse ubiquitin carboxyl-terminal esterase L5 (Uchl5), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR204843L2V | Lenti ORF particles, Uchl5 (GFP-tagged) - Mouse ubiquitin carboxyl-terminal esterase L5 (Uchl5), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR216635L1V | Lenti ORF particles, Uchl5 (Myc-DDK-tagged) - Mouse ubiquitin carboxyl-terminal esterase L5 (Uchl5), transcript variant 1, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
| MR204843L1V | Lenti ORF particles, Uchl5 (Myc-DDK-tagged) - Mouse ubiquitin carboxyl-terminal esterase L5 (Uchl5), transcript variant 2, 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||









+1 additional image
